Clinical Trial Update: Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating ABT-510 for safety and efficacy in locally advanced or metastatic soft tissue sarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• ABT-510 (ABT-510)

Snippet

Sponsor: Abbott | Conditions: Sarcoma, Soft Tissue | Phase 2 | Status: COMPLETED